Debunking the 7 Most Common Misconceptions of Colorectal Cancer

While largely preventable with early detection, 1 in 3 eligible Americans have never been screened for colorectal cancer. March is Colorectal Cancer Awareness Month and here are important clarifications on the common misconceptions around colorectal cancer. Misconception: Cancer is not preventable. A screening test can only detect cancer, it cannot prevent cancer. Cancer develops due to the uncontrolled division...

Lonza’s Cocoon Platform Brings Automated Cell-Therapy Manufacturing to the Clinic

A collaboration between Swiss-based Lonza and Sheba Medical Center at Tel Hashomer, the largest hospital in Israel and the Middle East region, is expected to result in a novel, point-of-care, cell-therapy manufacturing technology. The partnership, using Lonza's state-of-the-art CocoonTM manufacturing platform, will enable Sheba to vastly streamline its in-house cell...

Genetic Tests for Patients with Precursor Lesions Helps Understand Pancreatic Cancer Risk

A small, retrospective study, founded by the Sol Goldman Pancreatic Cancer Research Center at the Johns Hopkins University School of Medicine, Susan Wojcicki and Dennis Troper, the Lustgarten Foundation and others, shows that, in patients with particular pancreatic duct lesions, the presence of an inherited mutation in a pancreatic cancer susceptibility gene may increase the patients’ risk of developing...

Misdiagnosis of Colorectal Cancer May Be Common in People Younger than 50 Years of Age

Results of a survey funded by the Colorectal Cancer Alliance and presented during a preview meeting of the Annual Meeting of the America Association of Cancer Research (AACR), to be held March 29-April 3, 2019 in Atlanta, GA, a majority of patients diagnosed with colorectal cancer before age 50 were initially misdiagnosed. As a result of the misdiagnosis, this...

Studies on Origins of Colon Cancer may Lead to New and More Effective Therapies

Senior Research Scientist Bruce Boman, MD, Ph.D., MSPH, FACP, at the Helen F. Graham Cancer Center & Research Institute of Christiana Care Health System in Wilmington, DE , has received a U.S. $ 916,577 grant from the Lisa Dean Moseley Foundation to further stem cell research into the origins of colon cancer. Funding research and clinical programs undertaken by qualified...

Electromagnetic Navigation Bronchoscopy Shows Positive Response In Lung Cancer Study

An analysis of 12-month results from NAVIGATE, the largest, prospective, multicenter trial designed to evaluate outcomes following electromagnetic navigation bronchoscopy™ (ENB™) procedures using Medtronic's superDimension™ navigation system, shows positive results. Electromagnetic navigation bronchoscopy™ is a minimally invasive technology that guides endoscopic tools to pulmonary lesions.  The technology has been evaluated primarily in small, single-center studies. NAVIGATE enrolled subjects at 37...

Scientists Discover Possible way to Make Resistant Melanomas Susceptible to Immunotherapy

Researchers at the Ludwig Cancer Research Institute,  an international community of scientists focused on cancer research, with headquarters in New York City, NY and Zürich, Switzerland, have uncovered a cellular mechanism by which melanomas that fail to respond to checkpoint blockade may be made susceptible to such immunotherapies. The study, led by Ping-Chih Ho of the Lausanne Branch of...

Minimally Invasive Endoscopy Tool may Change Treatment for Pancreatic Cancer Patients

A minimally invasive treatment option may change treatment options for patients with pancreatic cancer. The development of significantly more effective treatment options is possible as a result of an endoscopy tool created by a team at the Penn State Department of Mechanical Engineering. The location of the pancreas in the abdomen and the difficulty to detect the disease make it...

Dr. Brawley Goes to Baltimore…and Washington

The latest chapter in Otis W. Brawley, MD’s illustrious career in cancer prevention and control commenced earlier this month when he began his tenure as a Bloomberg Distinguished Professor at Johns Hopkins University in Baltimore. During an exclusive interview with Onco’Zine, Brawley, 59, followed up on his promise in November to share information about what he then termed as a...

Study Shows How Molecular Profiling may Help Catch Lung Cancer Early, Leading to New Treatments

The world's first genetic sequencing of precancerous lung lesions, referred to as lung carcinoma in situ (CIS) are the preinvasive precursor to squamous cell carcinoma and could pave the way for very early detection and new treatments. A new study published in Nature Medicine by researchers from University College London (UCL) describes the cellular basis of a previously unknown clinical...

right side

ads

Related articles